Allspring Global Investments Holdings, LLC, a registered investment adviser, initiated a new position in Charles River Laboratories International, Inc. (NYSE:CRL) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 1,970,741 shares of the Healthcare company, valued at approximately $398,917,393 as of the filing date.
Charles River Laboratories International, Inc.'s stock currently trades at $224.00 with a market capitalization of $9,565,193,764.
